Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items
Navigating in the fog: Why the OBR should hold its nerve on the productivity forecast
The fiscal watchdog is under pressure to downgrade its forecast, costing the chancellor billions – but this would be premature.Everyday concerns: What people want from transport
Transport has a key role to play in achieving the UK government's missions and improving lives.Reforming gambling taxation: How to lift half a million children out of poverty
A key priority for the government’s upcoming child poverty strategy should be to remove the two-child limit and scrap the household benefit cap.